کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5533372 | 1402121 | 2016 | 15 صفحه PDF | دانلود رایگان |

- Replication of the apicoplast genome of Plasmodium falciparum sustains malaria infections.
- Apicoplast DNA polymerase (apPOL) is a bacterially derived atypical A-family polymerase.
- Divergent structural features of apPOL revealed here are probed by mutagenesis.
- Truncation of the novel N-terminal region eliminates apPOL proofreading activity.
- A known antimalarial compound is an in vitro inhibitor of apPOL.
Plasmodium falciparum, the primary cause of malaria, contains a non-photosynthetic plastid called the apicoplast. The apicoplast exists in most members of the phylum Apicomplexa and has its own genome along with organelle-specific enzymes for its replication. The only DNA polymerase found in the apicoplast (apPOL) was putatively acquired through horizontal gene transfer from a bacteriophage and is classified as an atypical A-family polymerase. Here, we present its crystal structure at a resolution of 2.9 à . P. falciparum apPOL, the first structural representative of a plastidic A-family polymerase, diverges from typical A-family members in two of three previously identified signature motifs and in a region not implicated by sequence. Moreover, apPOL has an additional N-terminal subdomain, the absence of which severely diminishes its 3ʹ to 5ʹ exonuclease activity. A compound known to be toxic to Plasmodium is a potent inhibitor of apPOL, suggesting that apPOL is a viable drug target. The structure provides new insights into the structural diversity of A-family polymerases and may facilitate structurally guided antimalarial drug design.
Graphical Abstract309
Journal: Journal of Molecular Biology - Volume 428, Issue 20, 9 October 2016, Pages 3920-3934